Funding Rounds
SparingVision Series A (2020, $52M)
SparingVisionSparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
Summary
Stage: Series A
Raised Amount: $52.81M
Raised Date: 2020-01-01
Stage: Series A
Raised Amount: $52.81M
Raised Date: 2020-01-01
